HIV and Vaccine Development

Immunizations are an important part of your HIV care plan because they can help protect you from serious illness. Vaccination recommendations are determined by weighing the benefits of vaccination against the risks. Although vaccination recommendations for HIV-infected patients are similar to those for HIV-uninfected patients in many respects, HIV can alter the efficacy and safety of vaccines and affect the susceptibility of the patient to the diseases for which immunization can confer protection. Thus, HIV infection impacts both the risks and the benefits of specific vaccinations.

  • Adjuvants
  • Therapeutic vaccines
  • Cell-based preventative vaccines

Related Conference of HIV and Vaccine Development

August 21-23, 2017

3rd Annual Congress on Infectious Diseases

San Francisco, California, USA
September 7-9, 2017

6thEuro-Global Conference on Infectious Diseases

Paris, France
September 13-14, 2017

6th Annual Bacteriology and Parasitology Meeting

Singapore
October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs


(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA
November 06-07, 2017

3rd International Conference on Flu and Emerging Infectious Diseases

Las Vegas, Nevada, USA
December 07-08, 2017

EuroSciCon Conference on STD-AIDS

Rome, Italy
March 1-2, 2018

5th International congress on Infectious Diseases

Berlin, Germany
June 11-12, 2018

4th World Congress on Rare Diseases and Orphan Drugs

Dublin, Ireland
August 13-14,2018

Global Experts Meeting on Infectious Diseases

Tokyo,Japan
31st August-1st September 2018

International Conference on Emerging Infectious Diseases

Zurich, Switzerland

HIV and Vaccine Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in